临时血管内右心室辅助装置桥接的心脏移植候选者的等待名单与移植结局
该分析基于2008至2022年美国器官共享联合网络登记数据,将等待心脏移植且使用临时血管内右心室辅助装置(tRVAD)的患者与无tRVAD者倾向性匹配。结果显示tRVAD与等待名单死亡/恶化风险升高相关(风险比2.2,95%CI 1.4-3.2,p<0.001),移植后1年死亡风险亦增加。
要点
- 41,507例心脏移植候选者中133例(0.3%)使用tRVAD。
- tRVAD组等待名单死亡/恶化风险比为2.2(95%CI 1.4-3.2,p<0.001)。
- tRVAD与移植后1年死亡风险增加相关。
核心结论
- tRVAD桥接不常见,主要用于需要双心室支持的患者。
- tRVAD与等待名单失活或死亡相关,尤其当同时使用临时左心室辅助装置时。
- 临时装置作为心脏移植桥接的使用日益增多,tRVAD患者结局应供未来分配政策参考,尤其是双心室衰竭候选者。
研究设计与样本
- 回顾性分析美国器官共享联合网络登记数据,纳入2008至2022年等待心脏移植的患者,按等待名单期间是否使用tRVAD分组并进行倾向性匹配。
- 采用竞争风险回归模型分析等待名单结局,竞争结局为死亡/恶化导致等待名单失活。
- 亚组分析比较使用持久性与临时性左心室辅助装置(LVAD)且伴或不伴tRVAD患者的等待名单结局。
- 采用Kaplan-Meier分析估算移植后1年死亡率。
主要发现
- 41,507例心脏移植候选者中,133例(0.3%)使用tRVAD。
- 倾向性匹配后,tRVAD组与无tRVAD组获得心脏移植的可能性相似,但死亡/恶化风险升高(风险比2.2,95%CI 1.4-3.2,p<0.001)。
- tRVAD患者中84%同时使用LVAD。
- 在临时LVAD患者中,tRVAD与恶化/死亡风险升高相关;在持久性LVAD患者中未见此关联。
- 对于接受心脏移植的患者,tRVAD与倾向性匹配受者相比1年死亡风险增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advances in mechanical circulatory support and changes in allocation policy have shifted waitlisting practices for heart transplantation (HT) in the United States. This analysis reports waitlist and transplant outcomes among HT candidates bridged with temporary endovascular right ventricular assist devices (tRVADs). METHODS: Patients awaiting HT from 2008 to 2022 in the United Network of Organ Sharing registry were grouped by the presence of tRVAD while waitlisted and propensity matched. Waitlist outcomes were HT and a competing outcome of death/deterioration requiring waitlist inactivation. Competing-risks regression was used to model waitlist outcomes. Subanalyses were performed to compare waitlist outcomes among patients with durable and temporary left ventricular assist devices (LVADs) with and without concomitant tRVADs. One-year posttransplant mortality was estimated using Kaplan-Meier analysis. RESULTS: Of 41,507 HT candidates, 133 (0.3%) had tRVADs. After propensity matching, patients with tRVAD had a similar likelihood of HT and an elevated hazard for death/deterioration (hazard ratio 2.2, 95% confidence interval 1.4-3.2, p < 0.001) compared to those without tRVAD. Most patients with tRVAD (84%) had concomitant LVADs. tRVAD was associated with an elevated risk for deterioration/death among those with temporary LVADs but not durable LVADs. For patients undergoing HT, tRVAD was associated with an increased risk for 1-year mortality compared to propensity-matched recipients. CONCLUSIONS: Bridging with tRVAD is uncommon and primarily used in patients requiring biventricular support. tRVADs are associated with waitlist inactivation or death, particularly with concomitant temporary LVAD support. As temporary devices are increasingly used as a bridge to HT, outcomes of patients with tRVADs should inform future allocation policy, particularly for candidates with biventricular failure.
引用
- Kwon JH, Skidmore SH, Bhandari K, et al. Waitlist and transplant outcomes in heart transplant candidates bridged with temporary endovascular right ventricular assist devices. J Heart Lung Transplant. 2023. PMID: 37951321. doi:10.1016/j.healun.2023.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。